Primary Record
carbamazepine
- In stock
- 7,123 g
- Purity
- 99.3 %
- CAS
- 298-46-4
Compound Identifiers & Properties
- CAS
- 298-46-4
- PubChem CID
- 2554
- SMILES
- C1=CC=C2C(=C1)C=CC3=CC=CC=C3N2C(=O)N
- Canonical SMILES
- NC(=O)N1c2ccccc2C=Cc2ccccc21
Names & Synonyms
- carbamazepine
- Tegretol
- Finlepsin
- Tegretal
- Biston
- Carbamazepen
- Telesmin
- Equetro
- Carbazepine
- Timonil
- Carbamezepine
- Karbamazepin
- Carbatrol
- Stazepine
- Neurotol
- Epitol
- 298-46-4
- Carbamazepin
- Lexin
- Tegretol-Xr
- Teril
- Carbamazepinum
- Carbamazepina
- Carnexiv
- Sirtal
- Amizepin
- Bipotrol
- Stazepin
- 5H-Dibenz[b,f]azepine-5-carboxamide
- 5H-Dibenzo[b,f]azepine-5-carboxamide
- Calepsin
- Karbelex
- Neurotop
- Carbamazepan
- Carbelan
- Trimonil
- Carbamazepine-D10
- Geigy 32883
- Tegretol Cr
- Carbazepin
- Carbmazepine
- Amizepine
- Carbamat
- Tegretol XR
- Atretol
- Epimaz
- Neurotop retard
- Carbamazepine?
- Carbagamma;
- Carbagen sr
- Carbamazepine Anhydrous
- Epimaz ret
- Novo-Carbamaz
- Sirtal ret
- Tegretol chewtab
- Neurotop;
- Tegretol;
- Teril ret
- Nu-Carbamazepine
- Arbil mr
- Atretol;
- Carbium;
- Prozine;
- Timonil;
- Carbamazepine ER
- Carbamazepine RS
- Epimaz;
- Epitol;
- Sirtal;
- Apo-Carbamazepine
- Tegretol Chewtabs
- Carba;
- Carbamazepine-D2
- Carbamazepine-D8
- Teril;
- Carbamazepine CRS
- Taro-Carbamazepine
- Tegretol (TN)
- Prestwick_104
- benzo[b][1]benzazepine-11-carboxamide
- Equetro (TN)
- carbamazepine hydrate
- carbamazepine sulfate
- Timonil 200 ret
- Timonil 400 ret
- 5-Carbamyl-5H-dibenzo(b,f)azepine
- carbamazepine tartrate
- Carbamazepine, powder
- 5-Carbamoyl-5H-dibenzo(b,f)azepine
- Taro-Carbamazepine Cr
- Carbamazepine dihydrate
- Carbamazepine Phosphate
- Carbamazepinum [INN-Latin]
- Carbatrol extended-release
- Opera_ID_72
- C15H12N2O
- RefChem:5646
- 5H-Dibenz(b,f)azepine-5-carboxamide
- Spectrum_000096
- 5-Carbamoyl-5H-dibenz(b,f)azepine
- Carbamazepina [INN-Spanish]
- Carbamazepine-d2 (Major)
- Carbamazepine extended release
- CHEMBL108
- carbamazepine (Tegretol)
- Carbamazepine (Standard)
- MFCD00005073
- AC1L1DXT
- AC1Q4ZSU
- AC1Q4ZSV
- 5-Carbamoyl-5H-dibenz[b,f]azepine
- Oxcarbazepine EP Impurity A
- Prestwick0_000052
- Prestwick1_000052
- Prestwick2_000052
- Prestwick3_000052
- Spectrum2_000125
- Spectrum3_000325
- Spectrum4_000262
- Spectrum5_000936
- Carbamazepine (Carbatrol)
- CHEBI:3387
- Lopac-C-4024
- Tegretol prolonged release
- FFGPTBGBLSHEPO-UHFFFAOYSA-N
- Carbamazepine Hydrochloride
- ChemDiv1_018966
- CARBAMAZEPINE [MI]
- DTXSID4022731
- CBChromo1_000350
- D04MSM
- Epitope ID:174842
- Iminostilbene-N-carboxamide
- 5-Carbamyldibenzo(b,f)azepine
- CARBAMAZEPINE [INN]
- CARBAMAZEPINE [JAN]
- HSDB 3019
- G-32883
- MLS000069652
- 5-Carbamoyldibenzo(b,f)azepine
- DTXCID902731
- CARBAMAZEPINE [HSDB]
- CARBAMAZEPINE [USAN]
- Lopac0_000292
- Oprea1_790775
- SCHEMBL21639
- BSPBio_000203
- BSPBio_001929
- Carbamazepine (iv, epilepsy)
- CARBAMAZEPINE [VANDF]
- KBioGR_000724
- KBioSS_000516
- UNII-33CM23913M
- MLS001055475
- MLS001074172
- MLS002548877
- BIDD:GT0479
- CARBAMAZEPINE [MART.]
- DivK1c_000388
- DivK1c_003750
- NSC 169864
- NSC-169864
- SPECTRUM1500159
- EINECS 206-062-7
- G 32883
- SPBio_000170
- SPBio_002124
- CARBAMAZEPINE [USP-RS]
- CARBAMAZEPINE [WHO-DD]
- CARBAMAZEPINE [WHO-IP]
- CARBAMAZEPINE, U.S.P.
- dibenzo[b,f]azepine-5-carboxamide
- NSC169864
- BPBio1_000225
- GTPL5339
- orb1310147
- ZINC4785
- 33CM23913M
- SCHEMBL29360181
- SCHEMBL29433237
- ERK5-1O15
- HMS501D10
- HMS640O02
- HY-B0246R
- KBio1_000388
- KBio2_000516
- KBio2_003084
- KBio2_005652
- KBio3_001149
- WLN: T C676 BNJ BVZ
- AOB5783
- BRN 1246090
- Carbamazepine (JP18/USP/INN)
- Carbamazepine [USAN:INN:BAN:JAN]
- CBZ;NSC 169864
- CID2554
- N03AF01
- SPD-417
- Carbamazepine - Bio-X trade mark
- Carbamazepine, analytical standard
- NINDS_000388
- s1693
- Carbamazepine, 1mg/ml in Methanol
- GLXC-06091
- HMS1568K05
- HMS1920I17
- HMS2090M07
- HMS2091O19
- HMS2095K05
- HMS2233G16
- HMS3039K09
- HMS3259B21
- HMS3260L06
- HMS3372J13
- HMS3657G03
- HMS3712K05
- HMS3747E03
- HMS5079B14
- HMS6018K08
- Pharmakon1600-01500159
- CARBAMAZEPINE [ORANGE BOOK]
- ACT02606
- BCP21380
- HY-B0246
- KS-00000KI8
- MSK10039
- PXB90221
- 5-Carbamoyl-5H-dibenzo[b,f]azepine
- 5-Carbomoyl-5H-dibenzo(b,f)azepine
- CARBAMAZEPINE [EP MONOGRAPH]
- CARBAMAZEPINE [USP IMPURITY]
- Tox21_110104
- Tox21_202273
- Tox21_300195
- Tox21_500292
- AC2074
- BDBM50003659
- c1095
- C15-H12-N2-O
- Carbamazepine [USAN:BAN:INN:JAN]
- CARBAMAZEPINE [USP MONOGRAPH]
- CCG-38931
- EBC-11073
- NCGC00015234-11
- NSC755920
- STK177357
- STL453548
- 11-benzo[b][1]benzazepinecarboxamide
- 5H-Dibenz[b,f]azepine-5-carboxamine
- 5H-Dibenzo(b,f)azepin-5-carboxamide
- Carbamazepine [USAN:USP:INN:BAN:JAN]
- Carbamazepine 1.0 mg/ml in Methanol
- Carbamazepine EPCRS (C0450000)
- CARBAMAZEPINUM [WHO-IP LATIN]
- CAS-298-46-4
- SMR000058201
- AKOS003235644
- AKOS025397243
- Tox21_110104_1
- 5H-Dibenz[b,f]azepine-5- carboxamide
- AC-9538
- AN-6325
- benzo(b)(1)benzazepine-11-carboxamide
- Carbamazepine (iv, epilepsy), Lundbeck
- Carbamazepine, 98% - 100G 100g
- CS-2225
- DB00564
- J8.590A
- KS-5146
- LP00292
- NC00679
- NSC-755920
- SDCCGSBI-0050280.P005
- 5H-Dibenz[ b, f]azepine-5-carboxamide
- CDS1_002710
- IDI1_000388
- 5H-Dibenzo[b,f]azepine-5-carboxamide #
- NCGC00015234-01
- NCGC00015234-02
- NCGC00015234-03
- NCGC00015234-04
- NCGC00015234-05
- NCGC00015234-06
- NCGC00015234-07
- NCGC00015234-08
- NCGC00015234-09
- NCGC00015234-10
- NCGC00015234-12
- NCGC00015234-13
- NCGC00015234-14
- NCGC00015234-15
- NCGC00015234-16
- NCGC00015234-18
- NCGC00015234-19
- NCGC00015234-33
- NCGC00023877-03
- NCGC00023877-04
- NCGC00023877-05
- NCGC00023877-06
- NCGC00023877-07
- NCGC00023877-08
- NCGC00253982-01
- NCGC00259822-01
- NCGC00260977-01
- 5-20-08-00247 (Beilstein Handbook Reference)
- 5H-Dibenz[b,f]-nu-azepine-5-carboxamide
- AJ-08227
- AJ-08230
- AK116064
- BC166161
- BC200975
- CPD001227191
- H495
- LS-60362
- SAM002264603
- SC-16243
- SMR001227191
- ST075773
- SY002823
- ZB000594
- Carbamazepine; Oxcarbazepine EP Impurity A
- SBI-0050280.P004
- 5H-dibenzo[b,f]azepine-5-carboximidic acid
- AB0070254
- AB1009530
- DB-047659
- ST2418853
- B1390
- Dibenzo[b,f]azepine-5-carboxylic acid amide
- EU-0100292
- FT-0602927
- FT-0696814
- H2605
- NS00000207
- Oxcarbazepine EP Impurity A (Carbamazepine)
- SW220141-1
- EN300-21678
- OXCARBAZEPINE IMPURITY A [EP IMPURITY]
- A10179
- BIM-0050280.0001
- C 4024
- C06868
- Carbamazepine, meets USP testing specifications
- D00252
- 5H-Dibenz(b,f)azepine-5-carboxamide maleic acid
- 5H-Dibenz(b,f)azepine-5-carboxamide oxalic acid
- AB00051931-17
- AB00051931-18
- AB00051931_19
- AB00051931_20
- A820074
- Carbamazepine (<lt/> 100 microg/ml) in methanol
- F242225
- Q410412
- SR-01000000229
- A1200543
- carbamazepine host structure with maleic acid removed
- carbamazepine host structure with oxalic acid removed
- CBZ
- I06-0863
- SR-01000000229-2
- SR-01000000229-4
- SR-01000000229-7
- 5,6-dideuteriobenzo[b][1]benzazepine-11-carboxamide
- 5H-Dibenz(b,f)azepine-5-carboxamide DL-tartaric acid
- 5H-dibenzo[b,f]azepine-5-carboxamide;Oxcarbazepine IMpurity A
- BRD-K71799949-001-06-7
- BRD-K71799949-001-35-6
- BRD-K71799949-001-36-4
- Carbamazepine (iv, epilepsy), Ovation Pharmaceuticals
- 5H-Dibenzo[b,f]azepine-5-(~13~C,~15~N)carboxamide
- Carbamazepine, 97%, a sodium channel blocker - 1g 1g
- F0348-2551
- Z104508594
- 5H-Dibenz(b,f)azepine-5-carboxamide 4-hydroxybenzoic acid
- carbamazepine host structure with DL-tartaric acid removed
- Dibenzo[b,f]azepine-5-carboxylic acid amide(Carbamazepine)
- 1189902-21-3
- carbamazepine host structure with 4-hydroxybenzoic acid removed
- Carbamazepine, British Pharmacopoeia (BP) Reference Standard
- Carbamazepine, European Pharmacopoeia (EP) Reference Standard
- 2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
- Carbamazepine, United States Pharmacopeia (USP) Reference Standard
- 132183-78-9
- 2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,9,12,14-heptaene-2-carboxamide
- 2-azatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide
- 2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide
- 2-azatricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaene-2-carboxamide
- Carbamazepine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
- Carbamazepine, Pharmaceutical Secondary Standard; Certified Reference Material
- 1173022-00-8
- 1538624-35-9
- 206-062-7
- 5H-Dibenzo[b,f]azepine-5-carboxamide; Carbamazepine; Oxcarbazepine Imp. A (EP); 5-Carbamoyl-5H-dibenz[b,f]azepine; Amizepin; Biston; CBZ; Calepsin; Carbamazepen; Carbamazepin; Carbatrol; Carbazepine; Carbelan; Epitol; Finlepsin; G 32883; Geigy 32883; Karbamazepin; Karbelex; Karberol; NSC 169864; Neurotol; Neurotop; Sirtal; Stazepine; Tegretal; Tegretol; Tegretol XR; Telesmin; Timonil; Oxcarbazepine Impurity A
- Azapentacene; Sodium 5,12-dihydroazapentacene disulfonate; 5,12-Dihydroquinoxalino[2,3-b]phenazine sulfonate sodium salt
- N6W